Funding Received
$5.7 Million in 1 Round from 4 Investors
Most Recent Funding
$5.7 Million Series C on May 10, 2010
Headquarters:
Mainz
Description:
Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.
Categories:
Biotechnology
Website:
http://www.galantos.com

Company Details

Update

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer’s and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer’s dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.

Current Team (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Freiligrathstraße 12

    Mainz, 55131

    DEU